Herantis Pharma Oyj : Managers' Transactions – Mats Heiman
Herantis Pharma Plc
Company release 30 Oct 2020 at 9:00 am EET
Herantis Pharma Oyj – Managers’ Transactions
____________________________________________
Person subject to the notification requirement
Name: Heiman, Mats
Position: Closely associated person
(1): Person Discharging Managerial Responsibilities In Issuer
Name: Atteryd Heiman, Ingrid
Position: Member of the Board
Issuer: Herantis Pharma Oyj
LEI: 743700W4CQVYAT3WKK38
Notification type: INITIAL NOTIFICATION
Reference number: 743700W4CQVYAT3WKK38_20201029220801_12
____________________________________________
Transaction date: 2020-09-18
Venue: FIRST NORTH FINLAND (FNFI)
Instrument type: SHARE
ISIN: FI4000087861
Nature of the transaction: DISPOSAL
Transaction details
(1): Volume: 4,584 Unit price: 7.7 EUR
Aggregated transactions
(1): Volume: 4,584 Volume weighted average price: 7.7 EUR
____________________________________________
Transaction date: 2020-10-01
Venue: FIRST NORTH FINLAND (FNFI)
Instrument type: SHARE
ISIN: FI4000087861
Nature of the transaction: DISPOSAL
Transaction details
(1): Volume: 3,888 Unit price: 6.86 EUR
Aggregated transactions
(1): Volume: 3,888 Volume weighted average price: 6.86 EUR
____________________________________________
Transaction date: 2020-10-02
Venue: FIRST NORTH FINLAND (FNFI)
Instrument type: SHARE
ISIN: FI4000087861
Nature of the transaction: DISPOSAL
Transaction details
(1): Volume: 1,584 Unit price: 6.92 EUR
Aggregated transactions
(1): Volume: 1,584 Volume weighted average price: 6.92 EUR
______________________________________
Further information:
Julie Silber/Gabriela Urquilla
Tel: +46 (0)7 93 486 277/+46 (0)72-396 72 19
Email:ir@herantis.com
Certified Advisor: UB Securities Ltd, Finland: +358 9 25 380 225, Sweden: +358 40 5161400
Company website: www.herantis.com
Distribution:
Main media
www.herantis.com